Fingerprint
Dive into the research topics of 'JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals
Dionna W. Williams, Kathryn Anastos, Susan Morgello, Joan W. Berman
Research output: Contribution to journal › Article › peer-review
44
Scopus
citations